US 11007217
Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy
granted A61KA61K31/675A61K33/00
Quick answer
US patent 11007217 (Compositions comprising nanosilica particles and their use in methods of activating T lymphocytes for therapy) held by United Kingdom Research and Innovation expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- United Kingdom Research and Innovation
- Grant date
- Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/675, A61K33/00, A61K9/14, A61P